Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Aswani Thurlapati"'
Autor:
Javaria Ahmad, Aswani Thurlapati, Sahith Thotamgari, Udhayvir Singh Grewal, Aakash Rajendra Sheth, Dipti Gupta, Kavitha Beedupalli, Paari Dominic
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundSeveral anti-cancer drugs have been linked to new onset atrial fibrillation (AF) but the true association of these drugs with AF is unknown. The FDA Adverse Event Reporting System (FAERS), a publicly available pharmacovigilance mechanism pr
Externí odkaz:
https://doaj.org/article/ae7fdefc4d3c4b59ba0877b907a75786
Autor:
Kelly Gaffney, Jonathan Bakos, Arash Velayati, James Davis, Aswani Thurlapati, Erin Weeda, Andy Maldonado, Katelynn Granger, Coleen Butcher, Taylor Herrington, Deidra Smith, Kimberly Green, Brian Hess, Hamza Hashmi
Introduction: High-dose chemotherapy-autologous stem cell transplant (HDT-ASCT) improves both depth and duration of remission for patients with transplant-eligible newly diagnosed multiple myeloma (NDMM). Whether certain subgroups of NDMM derive the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f42004f4cd6aaf19fb4100c8cec3c31
https://doi.org/10.21203/rs.3.rs-2886938/v1
https://doi.org/10.21203/rs.3.rs-2886938/v1
Autor:
James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess
Publikováno v:
Blood.
COVID-19 still represents a major issue for patients with lymphoid malignancies, especially those on therapy, because of immune suppression and suboptimal responses to vaccination. Davis et al report on their experience with double dose tixagevimab-c
Publikováno v:
Proc (Bayl Univ Med Cent)
Adult T-cell leukemia-lymphoma caused by human T-lymphotropic virus type 1 is a rare and aggressive tumor with high morbidity and mortality. Historically it has been treated with chemotherapy, but more recent studies suggest improvement in survival w
Autor:
Aswani Thurlapati, James A Davis, Syed Z Shah, Deidra Smith, Mary McGann, Kelly Gaffney, Kiera Roubal, Alyssa M Cendagorta, Andy Maldonado, Mr. Hamza Hashmi
Publikováno v:
Transplantation and Cellular Therapy. 29:S409-S410
Autor:
James A Davis, Syed Z Shah, Aswani Thurlapati, Kelly Gaffney, Mrs. Kristy Martin, Yolanda Williams, Mr. Hamza Hashmi
Publikováno v:
Transplantation and Cellular Therapy. 29:S408-S409
Publikováno v:
Cureus.
Publikováno v:
Cureus
Myosin heavy chain 9 (MYH9)-related hereditary macrothrombocytopenia is caused by mutation of the MYH9 gene encoding the heavy chain A of non-muscle myosin of class II. We present a case that emphasizes the importance of awareness of rare disorders w
Autor:
Javaria Ahmad, Aswani Thurlapati, Sahith Thotamgari, Udhayvir Singh Grewal, Aakash Rajendra Sheth, Dipti Gupta, Kavitha Beedupalli, Paari Dominic
Publikováno v:
Frontiers in cardiovascular medicine. 9
BackgroundSeveral anti-cancer drugs have been linked to new onset atrial fibrillation (AF) but the true association of these drugs with AF is unknown. The FDA Adverse Event Reporting System (FAERS), a publicly available pharmacovigilance mechanism pr
Publikováno v:
Cureus
The current treatment of choice for polyarthralgia in Crohn’s disease consists of disease-modifying agents and anti-inflammatory therapy, such as anti-tumor-necrosis-factor alpha inhibitors like infliximab. However, here we report the case of a pat